Overview

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the pharmacokinetics, efficacy, and safety of perampanel oral suspension on seizure frequency in pediatric participants maintained on one to three stable antiepileptic drugs
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Inc.